Crescent Biopharma, Inc. SEC filings CBIO
Crescent Biopharma, Inc. has 676 filings in SEC EDGAR's recent list, going back to Jul 10, 2003. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 30, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 2, 2026 |
| DEFA14A | Additional proxy material | Jan 13, 2025 | — |
| DEFA14A | Additional proxy material | Nov 7, 2024 | — |
| DEFA14A | Additional proxy material | Oct 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 1, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | May 1, 2024 |
| DEF 14A | Proxy statement | Apr 21, 2023 | May 19, 2023 |
| DEF 14A | Proxy statement | Apr 11, 2022 | May 18, 2022 |
| DEF 14A | Proxy statement | Apr 5, 2021 | May 5, 2021 |
| DEFA14A | Additional proxy material | May 8, 2020 | — |
| DEF 14A | Proxy statement | Apr 16, 2020 | May 22, 2020 |
| DEF 14A | Proxy statement | Apr 10, 2019 | May 17, 2019 |
| DEF 14A | Proxy statement | Apr 13, 2018 | May 18, 2018 |
| DEF 14A | Proxy statement | Apr 20, 2017 | May 25, 2017 |
| DEF 14A | Proxy statement | Apr 11, 2016 | May 17, 2016 |
| DEF 14A | Proxy statement | Jun 15, 2015 | Jul 15, 2015 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1253689
- Former names
- GLYCOMIMETICS INC (until Jun 23, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.